Heinz Ludwig
- Hematology top 0.02%
- Oncology top 0.1%
- Molecular Biology top 0.5%
- Genetics top 0.2%
- Pulmonary and Respiratory Medicine top 2%
- Co-authors
- E. FritzJesús F. San MiguelNiklas ZojerMeletios Α. DimopoulosHeinz GisslingerPieter SonneveldCarsten BokemeyerJoan Bladé
- Topics
- Multiple Myeloma Research and Treatments (212 papers)Protein Degradation and Inhibitors (77 papers)Cancer Treatment and Pharmacology (50 papers)
- Cited by
- HematologyOncologyGenetics
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Heinz Ludwig
358 papers receiving 16.2k citations
Hit Papers
Peers
Comparison fields: 5 of 151
- Hematology 10.8k
- Oncology 8.0k
- Molecular Biology 6.9k
- Genetics 2.6k
- Pulmonary and Respiratory Medicine 1.3k
Countries citing papers authored by Heinz Ludwig
This map shows the geographic impact of Heinz Ludwig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heinz Ludwig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heinz Ludwig more than expected).
Fields of papers citing papers by Heinz Ludwig
This network shows the impact of papers produced by Heinz Ludwig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heinz Ludwig. The network helps show where Heinz Ludwig may publish in the future.
Co-authorship network of co-authors of Heinz Ludwig
This figure shows the co-authorship network connecting the top 25 collaborators of Heinz Ludwig. A scholar is included among the top collaborators of Heinz Ludwig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heinz Ludwig. Heinz Ludwig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 5 | |
| 4 | Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panelbreakdown → | 77 |
| 5 | 5 | |
| 6 | 5 | |
| 7 | 28 | |
| 8 | 31 | |
| 9 | 1 | |
| 10 | 2 | |
| 11 | 1 | |
| 12 | 2 | |
| 13 | 1 | |
| 14 | 58 | |
| 15 | 148 | |
| 16 | 1 | |
| 17 | 5 | |
| 18 | 16 | |
| 19 | Clinical immunology and allergology : proceedings of the symposia at the XIth Congress of the European Academy of Allergology and Clinical Immunology held in Vienna, Austria, 6-10 October 1980 | 1 |
| 20 | 11 |
About Heinz Ludwig
Heinz Ludwig is a scholar working on Hematology, Genetics and Oncology, having authored 372 papers that have together received 16.8k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (212 papers), Protein Degradation and Inhibitors (77 papers) and Cancer Treatment and Pharmacology (50 papers). The work is most often cited by research in Hematology (10.8k citations), Oncology (8.0k citations) and Genetics (2.6k citations). Heinz Ludwig has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include E. Fritz, Jesús F. San Miguel, Niklas Zojer, Meletios Α. Dimopoulos, Heinz Gisslinger, Pieter Sonneveld, Carsten Bokemeyer, Joan Bladé, Pere Gascón and Mario Boccadoro. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.